Citation: | RUAN Peisen, ZHENG Yao, CHEN Hehe. Hemophagocytic lymphohistiocytosis secondary to chronic mucocutaneous candidiasis caused by gain-of-function STAT1 mutations: a case report[J]. Chinese Journal of General Practice, 2024, 22(3): 534-538. doi: 10.16766/j.cnki.issn.1674-4152.003443 |
[1] |
CAREY B, LAMBOURNE J, PORTER S, et al. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1 [J]. Oral Dis, 2019, 25(3): 684-692. doi: 10.1111/odi.12881
|
[2] |
ZHANG W J, CHEN X M, GAO G D, et al. Clinical relevance of gain- and loss-of-function germline mutations in STAT1 : a systematic review[J]. Front Immunol, 2021, 12: 654406. DOI: 10.3389/fimmu.2021.654406.
|
[3] |
BLANCO LOBO P, LEI W T, PELHAM S J, et al. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant[J]. Pediatr Allergy Immunol, 2021, 32(8): 1804-1812. doi: 10.1111/pai.13603
|
[4] |
OKADA S, ASANO T, MORIYA K, et al. Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy[J]. J Clin Immunol, 2020, 40(8): 1065-1081. doi: 10.1007/s10875-020-00847-x
|
[5] |
EGRI N, ESTEVE-SOLÉ A, DEYÀ-MARTÍNEZ À, et al. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches[J]. Allergol Immunopathol (Madr), 2021, 49(1): 118-127. doi: 10.15586/aei.v49i1.20
|
[6] |
CARRABBA M, DELLEPIANE R M, CORTESI M, et al. Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job' s syndrome[J]. Allergy Asthma Clin Immunol, 2023, 19(1): 32. doi: 10.1186/s13223-023-00776-5
|
[7] |
SHARIFINEJAD N, ZAKI-DIZAJI M, TEBYANIAN S, et al. Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review[J]. Expert Rev Clin Immunol, 2021, 17(8): 807-817. doi: 10.1080/1744666X.2021.1925543
|
[8] |
BLOOMFIELD M, ZENTSOVA I, MILOTA T, et al. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis[J]. Front Immunol, 2022, 13: 983977. DOI: 10.3389/fimmu.2022.983977.
|
[9] |
WANG X, ZHAO W W, CHEN F, et al. Chinese pedigree of chronic mucocutaneous candidiasis due to STAT1 gain-of-function mutation: a case study and literature review[J]. Mycopathologia, 2023, 188(1-2): 87-97. doi: 10.1007/s11046-022-00685-y
|
[10] |
JORDAN M B, ALLEN C E, GREENBERG J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)[J]. Pediatr Blood Cancer, 2019, 66(11): e27929. DOI: 10.1002/pbc.27929.
|
[11] |
CANNA S W, MARSH R A. Pediatric hemophagocytic lymphohistiocytosis[J]. Blood, 2020, 135(16): 1332-1343. doi: 10.1182/blood.2019000936
|
[12] |
KNAAK C, NYVLT P, SCHUSTER F S, et al. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore[J]. Crit Care, 2020, 24(1): 244. doi: 10.1186/s13054-020-02941-3
|
[13] |
GRIFFIN G, SHENOI S, HUGHES G C. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy[J]. Best Pract Res Clin Rheumatol, 2020, 34(4): 101515. DOI: 10.1016/j.berh.2020.101515.
|
[14] |
BILSTON L, CRODEN J, TAPARIA M, et al. Validation of the HScore and the HLH-2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort[J]. Eur J Haematol, 2022, 109(2): 129-137. doi: 10.1111/ejh.13779
|
[15] |
陈琼, 丁周志, 刘娜娜, 等. 不同年龄阶段EB病毒感染住院患儿临床症状及实验室检查特点分析[J]. 中华全科医学, 2021, 19(2): 241-244. doi: 10.16766/j.cnki.issn.1674-4152.001777
CHEN Q, DING Z Z, LIU N N, et al. Analysis on clinical characteristics and laboratory examination of Epstein-Barr virus infection in hospitalized children at different age stages[J]. Chinese Journal of General Practice, 2021, 19(2): 241-244. doi: 10.16766/j.cnki.issn.1674-4152.001777
|
[16] |
中国医师协会血液科医师分会, 中华医学会儿科学分会血液学组, 噬血细胞综合征中国专家联盟. 中国噬血细胞综合征诊断与治疗指南(2022年版)[J]. 中华医学杂志, 2022, 102(20): 1492-1499. doi: 10.3760/cma.j.cn112137-20220310-00488
Haematologists Branch of Chinese Medical Doctors Association, Haematology Group of Paediatrics Branch of Chinese Medical Association, Haemophagocytic Syndrome Chinese Expert Alliance. Guidelines for the diagnosis and treatment of haemophagocytic syndrome in China (2022)[J]. Chinese Medical Journal, 2022, 102(20): 1492-1499. doi: 10.3760/cma.j.cn112137-20220310-00488
|
[17] |
YANG W Y, LIU K Y, ZOU F L, et al. Hemophagocytic lymphohistiocytosis secondary to candida albicans and reactivated EBV infections: a case report and review of the literature[J]. Indian J Pathol Microbiol, 2021, 64(1): 192-194.
|
[18] |
程芬芬, 马宏浩, 焦莹, 等. 北京儿童医院改良噬血细胞性淋巴组织细胞增生症04方案疗效及安全性评价[J]. 中华儿科杂志, 2022, 60(8): 804-809. doi: 10.3760/cma.j.cn112140-20211109-00939
CHENG F F, MA H H, JIAO Y, et al. Efficacy and safety of modified hemophagocytic lymphohistiocytosis 04 regimen in Beijing Children ' s Hospital[J]. Chinese Journal of Pediatrics, 2022, 60(8): 804-809. doi: 10.3760/cma.j.cn112140-20211109-00939
|
[19] |
LA ROSÉE P, HORNE A, HINES M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019, 133(23): 2465-2477. doi: 10.1182/blood.2018894618
|
[20] |
LEHMANN D M, COHEN N, LIN I H, et al. Analyzing adherence to the 2016 infectious diseases society of America guidelines for candidemia in cancer patients[J]. Open Forum Infect Dis, 2022, 9(12): ofac555. DOI: 10.1093/ofid/ofac555.
|